Your browser doesn't support javascript.
loading
MMP-2-Controlled Transforming Micelles for Heterogeneic Targeting and Programmable Cancer Therapy.
Wang, Zihua; Wang, Yuehua; Jia, Xiangqian; Han, Qiuju; Qian, Yixia; Li, Qian; Xiang, Junfeng; Wang, Qian; Hu, Zhiyuan; Wang, Weizhi.
Afiliação
  • Wang Z; Center for Neuroscience Research, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian Province, 350108, China.
  • Wang Y; CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China.
  • Jia X; Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
  • Han Q; CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China.
  • Qian Y; CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China.
  • Li Q; CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China.
  • Xiang J; CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China.
  • Wang Q; Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
  • Hu Z; Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
  • Wang W; Department of Diagnostic Imaging National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.
Theranostics ; 9(6): 1728-1740, 2019.
Article em En | MEDLINE | ID: mdl-31037134
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Doxorrubicina / Metaloproteinase 2 da Matriz / Terapia de Alvo Molecular / Micelas / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Theranostics Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Doxorrubicina / Metaloproteinase 2 da Matriz / Terapia de Alvo Molecular / Micelas / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Theranostics Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China